Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (311-320 of 519) with videos related to

Pageof 52
Sort By:
JAMA Oncology|September 4, 2015
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort StudyOla Landgren, Youn K Shim, Joel Michalek, et al.
Arthritis and Rheumatism|March 4, 2008
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphomaLene Mellemkjaer, Ruth M Pfeiffer, Eric A Engels, et al.
Blood Cancer Journal|February 6, 2019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patientsDickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, et al.
Blood|September 26, 2012
A prospective study of circulating adipokine levels and risk of multiple myelomaJonathan N Hofmann, Linda M Liao, Michael N Pollak, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapiesMarios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
American Journal of Hematology|October 30, 2020
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myelomaMelissa Alsina, Ola Landgren, Noopur Raje, et al.
Experimental Hematology & Oncology|February 26, 2025
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow nicheHussein Ghamlouch, Dylan C Gagler, Patrick Blaney, et al.
Leukemia|December 15, 2019
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myelomaFrancesco Maura, Even H Rustad, Venkata Yellapantula, et al.
Environmental Health Perspectives|May 15, 2009
Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health StudyJennifer A Rusiecki, Rahulkumar Patel, Stella Koutros, et al.
Leukemia & Lymphoma|July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot studySham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Pageof 52

Showing results (311-320 of 519) with videos related to

Sort By:
Pageof 52
JAMA Oncology|September 4, 2015
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort StudyOla Landgren, Youn K Shim, Joel Michalek, et al.
Arthritis and Rheumatism|March 4, 2008
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphomaLene Mellemkjaer, Ruth M Pfeiffer, Eric A Engels, et al.
Blood Cancer Journal|February 6, 2019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patientsDickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, et al.
Blood|September 26, 2012
A prospective study of circulating adipokine levels and risk of multiple myelomaJonathan N Hofmann, Linda M Liao, Michael N Pollak, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapiesMarios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
American Journal of Hematology|October 30, 2020
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myelomaMelissa Alsina, Ola Landgren, Noopur Raje, et al.
Experimental Hematology & Oncology|February 26, 2025
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow nicheHussein Ghamlouch, Dylan C Gagler, Patrick Blaney, et al.
Leukemia|December 15, 2019
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myelomaFrancesco Maura, Even H Rustad, Venkata Yellapantula, et al.
Environmental Health Perspectives|May 15, 2009
Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health StudyJennifer A Rusiecki, Rahulkumar Patel, Stella Koutros, et al.
Leukemia & Lymphoma|July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot studySham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Pageof 52